Medico Remedies Limited (MEDICO.NS)
INR 58.75
(1.93%)
INR 58.75
(1.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 78.67 Million INR | -11.1% |
| 2022 | 88.5 Million INR | 7.02% |
| 2021 | 82.7 Million INR | -32.34% |
| 2020 | 122.22 Million INR | -7.62% |
| 2019 | 132.3 Million INR | -0.94% |
| 2018 | 133.55 Million INR | 7.93% |
| 2017 | 123.74 Million INR | -32.2% |
| 2016 | 182.51 Million INR | 38.83% |
| 2015 | 131.46 Million INR | 116.71% |
| 2014 | 60.66 Million INR | -14.22% |
| 2013 | 70.72 Million INR | 31.05% |
| 2012 | 53.96 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 78.67 Million INR | -8.74% |
| 2023 Q1 | 21.77 Million INR | -75.4% |
| 2023 FY | 78.67 Million INR | -11.1% |
| 2023 Q3 | 86.21 Million INR | 21.0% |
| 2023 Q2 | 71.24 Million INR | 227.26% |
| 2022 Q2 | 138.02 Million INR | 488.86% |
| 2022 FY | 88.5 Million INR | 7.02% |
| 2022 Q4 | 88.5 Million INR | 637.89% |
| 2022 Q3 | 11.99 Million INR | -91.31% |
| 2022 Q1 | 23.43 Million INR | -71.66% |
| 2021 FY | 82.7 Million INR | -32.34% |
| 2021 Q4 | 82.7 Million INR | 0.0% |
| 2021 Q2 | 106.09 Million INR | 0.0% |
| 2020 Q3 | 122.2 Million INR | 1.22% |
| 2020 Q1 | 120.73 Million INR | -8.75% |
| 2020 Q4 | 122.22 Million INR | 0.02% |
| 2020 Q2 | 120.73 Million INR | 0.0% |
| 2020 FY | 122.22 Million INR | -7.62% |
| 2019 Q1 | 145.23 Million INR | 8.75% |
| 2019 FY | 132.3 Million INR | -0.94% |
| 2019 Q4 | 132.3 Million INR | 6.2% |
| 2019 Q3 | 124.57 Million INR | -14.22% |
| 2019 Q2 | 145.23 Million INR | 0.0% |
| 2018 Q1 | 113.92 Million INR | -7.94% |
| 2018 FY | 133.55 Million INR | 7.93% |
| 2018 Q4 | 133.55 Million INR | 3.49% |
| 2018 Q3 | 129.05 Million INR | 13.28% |
| 2018 Q2 | 113.92 Million INR | 0.0% |
| 2017 FY | 123.74 Million INR | -32.2% |
| 2017 Q1 | 186.34 Million INR | 2.1% |
| 2017 Q2 | 186.34 Million INR | -0.0% |
| 2017 Q3 | 117.65 Million INR | -36.86% |
| 2017 Q4 | 123.74 Million INR | 5.17% |
| 2016 Q4 | 182.51 Million INR | 0.0% |
| 2016 FY | 182.51 Million INR | 38.83% |
| 2015 FY | 131.46 Million INR | 116.71% |
| 2014 FY | 60.66 Million INR | -14.22% |
| 2013 FY | 70.72 Million INR | 31.05% |
| 2012 FY | 53.96 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 97.965% |
| Hester Biosciences Limited | 2.29 Billion INR | 96.565% |
| Aarti Drugs Limited | 5.54 Billion INR | 98.582% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 96.988% |
| Albert David Limited | -278.36 Million INR | 128.264% |
| Alembic Limited | 66.9 Million INR | -17.604% |
| Alkem Laboratories Limited | -1.6 Billion INR | 104.889% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | 65.783% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 97.615% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 526.526% |
| Brooks Laboratories Limited | 49.48 Million INR | -58.992% |
| Eris Lifesciences Limited | 13.8 Billion INR | 99.43% |
| FDC Limited | -57.75 Million INR | 236.233% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 102.768% |
| Gufic Biosciences Limited | 3.19 Billion INR | 97.537% |
| Hikal Limited | 7.96 Billion INR | 99.012% |
| Ind-Swift Limited | 9.5 Billion INR | 99.173% |
| Innova Captab Limited | 2.33 Billion INR | 96.629% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 107.144% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 105.661% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 99.709% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 161.641% |
| Lupin Limited | 19.38 Billion INR | 99.594% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 91.937% |
| Morepen Laboratories Limited | -231.17 Million INR | 134.034% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 98.722% |
| Orchid Pharma Limited | -1.31 Billion INR | 105.988% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 103.351% |
| RPG Life Sciences Limited | -364.7 Million INR | 121.573% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 34.457% |
| Sigachi Industries Limited | 859.94 Million INR | 90.851% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 99.216% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 45.731% |
| Themis Medicare Limited | 764.96 Million INR | 89.715% |
| Unichem Laboratories Limited | 931.91 Million INR | 91.558% |
| Vaishali Pharma Limited | 119.13 Million INR | 33.96% |
| Wanbury Limited | 1.1 Billion INR | 92.886% |
| Windlas Biotech Limited | -273.04 Million INR | 128.815% |
| ZIM Laboratories Limited | 983.6 Million INR | 92.001% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 101.894% |
| Ipca Laboratories Limited | 11.41 Billion INR | 99.311% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 100.109% |
| Venus Remedies Limited | -267.7 Million INR | 129.39% |
| Sakar Healthcare Limited | 790.93 Million INR | 90.053% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 97.87% |
| Divi's Laboratories Limited | -39.77 Billion INR | 100.198% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 101.57% |
| Mankind Pharma Limited | -1.74 Billion INR | 104.5% |
| Sequent Scientific Limited | 4.17 Billion INR | 98.117% |
| Laurus Labs Limited | 24.35 Billion INR | 99.677% |
| Neuland Laboratories Limited | -214.05 Million INR | 136.755% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 97.211% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 101.836% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 97.989% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 131.624% |
| Wockhardt Limited | 18.27 Billion INR | 99.569% |
| Bal Pharma Limited | 1.26 Billion INR | 93.773% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 99.391% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 106.796% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 121.465% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 101.428% |
| Shilpa Medicare Limited | 9.06 Billion INR | 99.133% |
| Valiant Laboratories Limited | 649.9 Million INR | 87.894% |
| Ajanta Pharma Limited | -954.9 Million INR | 108.239% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | 73.561% |
| Granules India Limited | 9.28 Billion INR | 99.153% |
| Medicamen Biotech Limited | 160.31 Million INR | 50.924% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -70.256% |
| Piramal Enterprises Limited | 491.39 Billion INR | 99.984% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 99.753% |
| NATCO Pharma Limited | -5.81 Billion INR | 101.353% |
| Suven Life Sciences Limited | -1.63 Billion INR | 104.819% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 95.93% |
| Strides Pharma Science Limited | 23.25 Billion INR | 99.662% |
| Indoco Remedies Limited | 6.47 Billion INR | 98.785% |
| Alpa Laboratories Limited | 35.36 Million INR | -122.484% |
| Lasa Supergenerics Limited | 205.79 Million INR | 61.77% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 108.354% |